Pancytopenia

Definition | Aetiology | Pathophysiology | Risk Factors | Signs and Symptoms | Investigations | Management | References

Definition

Pancytopenia is a medical condition characterised by the reduction of all three cellular components of the blood: red blood cells, white blood cells, and platelets. This results in anaemia, leukopenia, and thrombocytopenia, respectively.

Aetiology

Pancytopenia can result from a variety of underlying causes, including:

  • Bone marrow failure (e.g., aplastic anaemia)
  • Bone marrow infiltration (e.g., leukaemia, myelodysplastic syndromes)
  • Infections (e.g., viral infections like HIV, hepatitis)
  • Medications and toxins (e.g., chemotherapy, radiation therapy, benzene)
  • Autoimmune disorders (e.g., systemic lupus erythematosus)
  • Genetic disorders (e.g., Fanconi anaemia)
  • Chronic liver disease

Pathophysiology

The pathophysiology of pancytopenia varies depending on the underlying cause:

  • Bone marrow failure: Due to direct damage to the hematopoietic stem cells.
  • Bone marrow infiltration: Replacement of normal marrow tissue with abnormal cells.
  • Peripheral destruction: Increased destruction of blood cells due to autoimmune processes or hypersplenism.

Risk Factors

  • Exposure to certain medications or toxins
  • Family history of haematological disorders
  • Chronic infections
  • Autoimmune diseases
  • Previous history of cancer or radiation therapy
  • Chronic liver disease

Signs and Symptoms

Common signs and symptoms of pancytopenia include:

  • Fatigue and weakness (due to anaemia)
  • Frequent infections (due to leukopenia)
  • Easy bruising and bleeding (due to thrombocytopenia)
  • Pallor
  • Shortness of breath
  • Dizziness
  • Petechiae and purpura

Investigations

  • Complete blood count (CBC) with differential
  • Peripheral blood smear
  • Bone marrow biopsy and aspiration
  • Serum vitamin B12 and folate levels
  • Liver function tests
  • Renal function tests
  • Viral serologies (e.g., HIV, hepatitis)
  • Autoimmune screening (e.g., ANA, anti-dsDNA)

Management

Primary Care Management

  • Immediate referral to a haematologist: For further evaluation and management
  • Supportive care:
    • Transfusions (red blood cells, platelets) as needed
    • Infection prevention (e.g., prophylactic antibiotics, vaccinations)
  • Monitoring: Regular follow-up with CBC and clinical assessment

Specialist Management

  • Treatment of underlying cause: Addressing the primary condition (e.g., chemotherapy for leukaemia, immunosuppressive therapy for autoimmune conditions)
  • Bone marrow transplant: For conditions like aplastic anaemia or severe myelodysplastic syndromes
  • Growth factor therapy: Erythropoietin, G-CSF to stimulate bone marrow production
  • Regular follow-up to monitor response to treatment and manage any complications

References

  1. Patient.info. (2024). Pancytopenia. Retrieved from Patient.info
  2. NHS. (2023). Pancytopenia. Retrieved from NHS
  3. British Medical Journal (BMJ). (2022). Pancytopenia: Diagnosis and Management. Retrieved from BMJ
  4. American Society of Hematology (ASH). (2021). Clinical Practice Guidelines: Pancytopenia. Retrieved from ASH

Back to Top

 
 
 

Check out our youtube channel

Donate
 

Jump to other topics below: